Conversely, TP53 mutations occurring prior to TET2 mutations could result in increased genomic instability and enhanced proliferation, with newly gained TET2 mutations mediating a switch of lineage from lymphoid- to myeloid-biased leukemia. The gene discussed is TET2; the disease is leukemia.